RxDoctor Payments Data

Tamara Onan

Physician Assistant · Newport Beach, CANPI 1477837862

Payments from drug & device makers

$11,913in general payments, 2019–2025

Across 532 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Alkermes, Inc.$900
  • Neurocrine Biosciences, Inc.$868
  • Vanda Pharmaceuticals Inc.$811
  • Ironshore Pharmaceuticals Inc.$730
  • AbbVie$679
  • plus $6K from 24 others

What the payments were for

  • Food & beverage$11,902100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,913 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl31$51,140
Lurasidone Hcl37$15,532
Aripiprazole23$1,825
Temazepam18$1,676
Quetiapine Fumarate93$1,646
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine20$1,538
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine34$1,129
Duloxetine Hcl41$852
Lamotrigine74$720
Gabapentin28$685
Fluvoxamine Maleate17$619
Divalproex Sodium33$425
Olanzapine21$412
Clonazepam92$402
Trazodone Hcl37$329

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$529$51,14031 claims
Lilly USA, LLCOlanzapine$118$41221 claims
Almatica Pharma LLCSertraline Hcl$31$6017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →